Sophia Genetics Sa (SOPH)

Überblick Nachrichten Preisverlauf Optionskette Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Sophia Genetics Sa Stock (SOPH) Company Profile

Sophia Genetics Sa

Healthcare (1200)

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SOPH's Discussions on Twitter

Vergleichen Sie SOPH mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SOPH Sophia Genetics Sa	3.27	215.93M	62.37M	-78.98M	-57.80M	-1.22
VEEV Veeva Systems Inc	226.76	36.93B	2.57B	615.26M	996.76M	3.32
SOLV Solventum Corp	72.48	12.43B	8.26B	66.00M	1.17B	0.00
TEM Tempus Ai Inc	62.98	10.01B	640.44M	-743.28M	-206.93M	0.00
DOCS Doximity Inc	53.39	9.94B	493.63M	160.55M	162.20M	0.55
HQY Healthequity Inc	102.47	8.91B	1.10B	105.67M	-197.98M	0.1475

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-08-07	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2024-06-27	Eingeleitet	Guggenheim	Buy
2023-11-29	Eingeleitet	RBC Capital Mkts	Outperform
2023-07-05	Fortgesetzt	JP Morgan	Overweight
2023-01-03	Eingeleitet	BTIG Research	Buy
2022-11-23	Eingeleitet	Credit Suisse	Neutral
2021-10-15	Fortgesetzt	Cowen	Outperform
2021-08-17	Eingeleitet	Cowen	Outperform
2021-08-17	Eingeleitet	Credit Suisse	Outperform
2021-08-17	Eingeleitet	JP Morgan	Overweight
2021-08-17	Eingeleitet	Morgan Stanley	Overweight

Alle ansehen

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Sophia Genetics Sa (SOPH)

Sophia Genetics Sa Stock (SOPH) Company Profile

Vergleichen Sie SOPH mit anderen Aktien

Sophia Genetics Sa Stock (SOPH) Upgrades & Downgrades

Sophia Genetics Sa Aktie (SOPH) Neueste Nachrichten

SOPHiA GENETICS Reports Third Quarter 2024 Results - GuruFocus.com

Principal Financial Group Inc. Acquires 86,764 Shares of SOPHiA GENETICS SA (NASDAQ:SOPH) - Defense World

SOPHiA GENETICS Launches Advanced Cancer Profiling Platform with 99.3% Accuracy | SOPH Stock News - StockTitan

SOPHiA GENETICS's SWOT analysis: data-driven medicine stock faces headwinds - Investing.com India

SOPHiA GENETICS (NASDAQ:SOPH) vs. SpringWorks Therapeutics (NASDAQ:SWTX) Financial Review - Defense World

Earnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00 - Yahoo Finance

SOPHiA GENETICS SA (NASDAQ:SOPH) Q3 2024 Earnings Call Transcript - Insider Monkey

Earnings call: SOPHiA GENETICS reported a16% year-over-year increase in analysis volume - Investing.com

SOPHiA GENETICS Third Quarter 2024 Earnings: Misses Expectations - Yahoo Finance

SOPHiA GENETICS Faces Financial Challenges Amid Losses - Yahoo Finance

Sophia Genetics SA (SOPH) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada

SOPHiA GENETICS Q3 2024 Financial Highlights - TipRanks

SOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial Officer - Marketscreener.com

3 Reasons Not to Give Up on Roku Stock - MSN

Vanguard Dethrones BlackRock As Second Largest ETF Manager: Here's How Their Funds With Exposure To S&P 500 Fared This Year - MSN

Cofle S.p.A. Enhances Share Buyback Strategy - MSN

Adma Biologics (ADMA) Soars 18.8%: Is Further Upside Left in the Stock? - MSN

Palantir, Trump Media Buzz Amid Investors Ahead Of Election Day - MSN

SOS Limited announces ADS ratio change - MSN

Exploring Sophia Genetics's Earnings Expectations - Benzinga

Denmark stocks lower at close of trade; OMX Copenhagen 20 down 1.16% - MSN

IPO Roundup: Heritage Distilling, Transten Global and more - MSN

SOPHiA GENETICS SA (SOPH): A Bull Case Theory - Insider Monkey

Sophia Genetics SA (SOPH) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Estimating at-risk couple rates across 1000 exome sequencing data cohort for 176 genes and its importance relevance for health policies - Nature.com

Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? - Yahoo Finance

Morgan Stanley Downgrades Biogen (BIIB) - MSN

The biggest U.S. homebuilder misses on earnings as it says buyers are staying on the sidelines - MSN

Clime Capital Announces Quotation of New Shares - MSN

SOPHiA GENETICS (SOPH) to Release Quarterly Earnings on Tuesday - MarketBeat

US Penny Stocks To Watch In October 2024 - Simply Wall St

SOPHiA GENETICS and Hitachi Announce Collaboration to Advance Data Driven Precision Medicine - AsiaOne

SOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024 - Marketscreener.com

Millennium Management LLC Purchases 9,199 Shares of Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO) - Defense World

SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Down 22.8% in September - MarketBeat

SOPHiA GENETICS SA (NASDAQ:SOPH) Shares Sold by Millennium Management LLC - MarketBeat

Artificial Intelligence (AI) in Precision Medicine Global Market Size, Trends 2024-2033 - WhaTech

The UAE Cerebrospinal Fluid Drainage Catheter Market Size & Outlook, 2030 - Grand View Research

Dynamic Advisor Solutions LLC Acquires 1,432 Shares of PepsiCo, Inc. (NASDAQ:PEP) - Defense World

Artificial Intelligence in Diagnostics Market to hit USD 7.3 billion by 2032, says Global Market Insights Inc. - GlobeNewswire Inc.

What to Expect From Labcorp Holdings' Q3 2024 Earnings Report - MSN

SOPHiA GENETICS' SWOT analysis: data-driven medicine firm faces headwinds - Investing.com

Artificial Intelligence In Cancer Diagnostics Market Size, Industry Analysis, Key Insights And Forecast To ... - WhaTech

SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Update - MarketBeat

SOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest Down 52.0% in September - Defense World

Federated Hermes Inc. Has $346,000 Stake in Photronics, Inc. (NASDAQ:PLAB) - Defense World

Global Precision medicine software Market Expected to Reach $ 3112.52 Million by 2032, Growing at 11.4% CAGR - 대구포스트

Analyzing SOPHiA GENETICS (NASDAQ:SOPH) & Cyclo Therapeutics (NASDAQ:CYTH) - Defense World

The Agenda Setter: SOPHIE’s posthumous new album cements a pop visionary’s legacy - Dork Magazine

Sosandar – AGM Due On Thursday For Women’s Fashion Group Now Recovering Into Profits, Shares Now 10p, Brokers Predict 31p - UK Investor Magazine

Sophie's life was saved by a stranger. Some in her position have an 'unfair' disadvantage - SBS News

Finanzdaten der Sophia Genetics Sa-Aktie (SOPH)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie SOPH